In this issue of Blood, Yeomans et al identify MYC as an important target for translational regulation in chronic lymphocytic leukemia (CLL) cells after B-cell receptor (BCR) stimulation and show that current therapies suppress this induction.
CITATION STYLE
Paggetti, J., & Moussay, E. (2016, January 28). BCR engagement in CLL: When translation goes wrong. Blood. American Society of Hematology. https://doi.org/10.1182/blood-2015-11-678623
Mendeley helps you to discover research relevant for your work.